UniSuper Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
UniSuper Management's BSX Position: Q2 2026 in Review
UniSuper Management increased its Boston Scientific (BSX) stake by 6.6% in Q2 2026, buying an estimated $2.57M and bringing the position to 767,067 shares worth $32.7M. The position accounts for 0.17% of the portfolio, ranked #109.
UniSuper Management first reported a position in BSX in Q2 2023 and has held it in 13 quarters since. The position peaked at $105M in Q3 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- UniSuper Management held 767,067 shares of Boston Scientific worth $32.7M as of Q2 2026.
- UniSuper Management bought 47,397 Boston Scientific shares in Q2 2026, an estimated $2.57M.
- Boston Scientific made up 0.17% of UniSuper Management's portfolio in Q2 2026, its #109 holding.
- UniSuper Management first reported a position in Boston Scientific in Q2 2023 and has held it in 13 quarters since.
- UniSuper Management's Boston Scientific position peaked at $105M in Q3 2025.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on UniSuper Management's 13F filing for Q2 2026, filed 14 Aug 2026.